ATORVASTATIN CALCIUM
- Product NDC
- 70934-091
- 11-digit product format
- 709340091
- Labeler code
- 70934
- Product ID
- 70934-091_b7def290-565c-7f4b-e053-2995a90abf2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA090548
- Marketing category
- ANDA
- Marketing start
- 2018-03-26
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-091-30 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | | 4 |
| 70934-091-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-091 | ATORVASTATIN CALCIUM TABLET, FILM COATED [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 4 | Legacy NDC, 2 package rows | 20210105_6eede7ca-0998-7038-e053-2991aa0a4e7c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-091-30 | 70934009130 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-091-30) | 2018-03-26 | 0000-00-00 | No | No | Current |
| 70934-091-90 | 70934009190 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-091-90) | 2018-12-13 | 0000-00-00 | No | No | Current |